Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2001

View Archived Issues

Investigational immunotherapy for Alzheimer's disease enters phase IIa

Diversa and IntraBiotics discontinue antimicrobial alliance

Cell Matrix awarded grants for development of novel antiangiogenesis products

Adaptive Screening offers new approach to drug discovery

Second-quarter development progress reported by Sepracor

JNK inhibitor appears to have disease-modifying activity in rheumatoid arthritis

Role of dipeptidyl-peptidase IV in GIP metabolism, biological activity

FDA advisory committee to review IntraDose

Corvas provides status report for rNAPc2

Pilot studies suggest that EPA may be a novel therapeutic option in schizophrenia

Neurocrine Biosciences and GSK establish collaboration for CRF receptor antagonists

QLT and Novartis Ophthalmics expand verteporfin codevelopment agreement

Methotrexate-albumin conjugate may be particularly useful against prostate cancer, sarcomas

ProChon and MorphoSys identify new class of antibody

Chlamydia candidate vaccine reveals potential to protect against STD-related infertility

Inhibitors of HIV fusion and entry a focus of interest at recent conference

Abgenix and CuraGen make progress in development of novel antibody drug targets

Survival prolonged in tumor-bearing mice treated with GTI-2040

Lovastatin reduces coronary event risk in subjects with elevated C-reactive protein levels

Use of BTK inhibitor LFM-A13 for inhibiting platelet aggregation

New antitumor compounds in development at Pharmacia

Abbott claims ketolide antibacterial agents in recent patent

Preparation of dihydroquinoline derivatives and use as analgesics

Heterocyclic compounds from Takeda may have therapeutic potential in diabetic neuropathy

Antifungal chromone derivatives reported by Toyama

Kyorin's new PPAR activators reportedly useful in diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...